Strongbridge Biopharma (SBBP) Prices 11.11M Share Common Offering at $2.25/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/25/2026
- US stock futures rise on tech rebound before Nvidia, inflation tests
- Oil hits one-week low as investors shrug off US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Grand Canyon Education places CFO on leave amid stock trade probe
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Funds sell $44bn in semiconductors on AI concerns
- Six Flags to move headquarters from Charlotte to Arlington, Texas
After-Hours Movers 9/16: (MLHR) (SCS) (MRNA) Higher; (SBBP) (NCNA) (FSLR) Lower (more...)
September 16, 2020 5:35 PM EDTAfter-Hours Movers
Herman Miller (NASDAQ: MLHR) 15.2% HIGHER; reported Q1 EPS of $1.24, $0.98 better than the analyst estimate of $0.26. Revenue for the quarter came in at $626.8 million versus the consensus estimate of $524.83 million.
Strongbridge Biopharma (SBBP) Announces Proposed Public Offering of Ordinary Shares
September 16, 2020 4:36 PM EDTStrongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that it intends to offer and sell ordinary shares in an underwritten public offering. The Company also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of... More
